Newron Pharmaceuticals S.p.A. (NWPHF)
OTCMKTS
· Delayed Price · Currency is USD
12.00
+0.60 (5.26%)
May 15, 2024, 9:30 AM EDT
Newron Pharmaceuticals Employees
Newron Pharmaceuticals had 22 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
22
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$2,418,376
Profits / Employee
$745,560
Market Cap
173.70M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
American Oncology Network | 1,914 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
Newron Pharmaceuticals News
- 5 weeks ago - Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS) - Business Wire
- 2 months ago - Newron Presents 2024 Financial Results and Provides 2025 Outlook - Business Wire
- 3 months ago - Newron Pharmaceuticals to Participate in a Fireside Chat at the 37th Annual ROTH Conference - Business Wire
- 5 months ago - Newron and Myung In Pharm Announce License Agreement for evenamide in South Korea - Business Wire
- 6 months ago - Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories - Business Wire
- 9 months ago - Newron presents H1 2024 results and provides business update - Business Wire
- 1 year ago - Newron Pharmaceuticals Reports on Its 2024 Investor Day in New York City - Business Wire
- 1 year ago - Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City - Business Wire